By Stephen Ruscus and Donna Lee Yesner ( July 13, 2018, 11:52 AM EDT) -- The U.S. Court of Federal Claims issued a decision in Acetris Health LLC v. United States on July 10, 2018,[1] invalidating U.S. Department of Veterans Affairs and U.S. Department of Defense interpretations of the trade agreements clause, 48 C.F.R. § 52.225-5, which had resulted in the agencies prohibiting offers of pharmaceuticals classified as domestic end products under the Buy American Act[2] if they were determined to be products of India or China (or other nonfavored countries) under the Trade Agreements Act,[3] which prohibits U.S. purchases of such products unless eligible products are unavailable....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.